Order Article Reprints

Gdowski A, Hayatshahi H, Fudala R, Joshi R, Liu J, Vishwanatha JK, Jeyarajah R, Guzik P, Ranjan AP. Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer. Pharmaceutics. 2022; 14(1):128. https://doi.org/10.3390/pharmaceutics14010128

Gdowski, Andrew, Hamed Hayatshahi, Rafal Fudala, Rohan Joshi, Jin Liu, Jamboor K. Vishwanatha, Rohan Jeyarajah, Paul Guzik, and Amalendu P. Ranjan. 2022. "Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer" Pharmaceutics 14, no. 1: 128. https://doi.org/10.3390/pharmaceutics14010128

Gdowski, A., Hayatshahi, H., Fudala, R., Joshi, R., Liu, J., Vishwanatha, J. K., Jeyarajah, R., Guzik, P., & Ranjan, A. P. (2022). Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer. Pharmaceutics, 14(1), 128. https://doi.org/10.3390/pharmaceutics14010128